- Filed
- Oct 11, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Mar 31, 2024 | 1.01M sh |
| Shares Diluted | FY 2024 · Mar 31, 2023 | 1M sh |
| Shares Outstanding | FY 2024 · Mar 31, 2024 | 1.03M sh |
| Operating Cash Flow | FY 2024 · Mar 31, 2024 | −$132.75K |
| Operating Cash Flow | FY 2024 · Mar 31, 2023 | −$306.09K |
| Cash And Equivalents | FY 2024 · Mar 31, 2024 | $82 |
| Cash And Equivalents | FY 2024 · Mar 31, 2023 | $9.87K |
| Stockholders Equity | FY 2024 · Mar 31, 2024 | −$406.88K |
| Stockholders Equity | FY 2024 · Mar 31, 2023 | −$1.32M |
| Stockholders Equity | FY 2024 · Mar 31, 2022 | −$835.62K |
| Current Liabilities | FY 2024 · Mar 31, 2024 | $451.79K |
| Current Liabilities | FY 2024 · Mar 31, 2023 | $1.41M |
| Total Liabilities | FY 2024 · Mar 31, 2024 | $451.79K |
| Total Liabilities | FY 2024 · Mar 31, 2023 | $1.41M |
| Current Assets | FY 2024 · Mar 31, 2024 | $44.91K |
| Current Assets | FY 2024 · Mar 31, 2023 | $25.55K |
| Total Assets | FY 2024 · Mar 31, 2024 | $44.91K |
| Total Assets | FY 2024 · Mar 31, 2023 | $92.93K |
| Eps Diluted | FY 2024 · Mar 31, 2024 | $0.78 |
| Eps Diluted | FY 2024 · Mar 31, 2023 | −$0.53 |
| Eps Basic | FY 2024 · Mar 31, 2024 | $0.78 |
| Eps Basic | FY 2024 · Mar 31, 2023 | −$0.53 |
| Sga Expense | FY 2024 · Mar 31, 2024 | $676.08K |
| Sga Expense | FY 2024 · Mar 31, 2023 | $587.64K |
| Net Income | FY 2024 · Mar 31, 2024 | $788.25K |
| Net Income | FY 2024 · Mar 31, 2023 | −$534.68K |
| Operating Income | FY 2024 · Mar 31, 2024 | −$671.08K |
| Operating Income | FY 2024 · Mar 31, 2023 | −$534.68K |
| Revenue | FY 2024 · Mar 31, 2024 | $5K |
| Revenue | FY 2024 · Mar 31, 2023 | $122.38K |
| Capex | FY 2024 · Mar 31, 2023 | $11.49K |
| Cost Of Revenue | FY 2024 · Mar 31, 2023 | $69.42K |